Compare FMS & ARCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FMS | ARCC |
|---|---|---|
| Founded | 1996 | 2004 |
| Country | Germany | United States |
| Employees | 108165 | N/A |
| Industry | Misc Health and Biotechnology Services | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 13.6B |
| IPO Year | N/A | 2004 |
| Metric | FMS | ARCC |
|---|---|---|
| Price | $24.31 | $19.88 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $30.00 | $21.36 |
| AVG Volume (30 Days) | 746.3K | ★ 4.5M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | 2.57% | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.77 |
| Revenue Next Year | $3.83 | $2.29 |
| P/E Ratio | ★ $15.62 | $153.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.02 | $17.40 |
| 52 Week High | $27.64 | $22.76 |
| Indicator | FMS | ARCC |
|---|---|---|
| Relative Strength Index (RSI) | 51.02 | 65.49 |
| Support Level | $23.55 | $19.82 |
| Resistance Level | $24.63 | $20.11 |
| Average True Range (ATR) | 0.50 | 0.33 |
| MACD | -0.14 | 0.11 |
| Stochastic Oscillator | 29.28 | 90.82 |
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.